Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Autism Spectrum Disorder (ASD) Clinical Trials

A listing of Autism Spectrum Disorder (ASD) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (207) clinical trials

The Children’s Research Unit at Albert Einstein College of Medicine in the Bronx, New York is currently recruiting participants in the area for a genetic study of African Americans with autism. We are looking for children of all ages who identify as African American and have a diagnosis or are ...

Phase N/A

The purpose of the study is to assess the efficacy of two highly requested treatments for children with autism spectrum disorder, both of which are directed at increasing functional skills and reducing maladaptive sensory behaviors: occupational therapy using sensory strategies for decreasing sensory dysfunction and applied behavioral analytic (ABA) therapy.

Phase N/A

Purpose of the study: The Children’s Research Unit at Albert Einstein College of Medicine of Yeshiva University are currently recruiting participants for a research study that examines whether multisensory integration (the brain’s processing of information from different senses) is impaired in people with autism. Protocol summary: Information from the various ...

Phase N/A

This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of RO5285119 in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [≥] 70). Enrollment will be staggered, ...

Phase N/A

People with autism spectrum disorder are asked to participate in a research study being conducted by Montefiore Medical Center.

This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of RO5285119 in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [>=] 70). Enrollment will be staggered, ...

Phase

A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder

IGF-1 is an FDA approved, commercially available compound that crosses the blood-brain barrier and has beneficial effects on synaptic development by promoting neuronal cell survival, synaptic maturation, and synaptic plasticity. IGF-1 is effective in reversing mouse and neuronal models of Rett syndrome and Phelan McDermid syndrome, both single gene causes ...

Phase

Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism?

The primary objective of this study is to undertake a longitudinal investigation of the impact of sleep and circadian rhythm disturbances on cognitive and behavioural trajectories in children with autism spectrum disorder (ASD) age 3-10 years old. This innovative study will use objective quantifiable measures of sleep and circadian rhythms ...

Phase N/A

Biomarker for Creatine Deficiency Syndromes

The creatine deficiency syndromes (CDS) are a group of inborn errors of metabolism which interrupt the biosynthesis or transportation of creatine. Individuals with creatine deficiency syndromes classically present with intellectual disabilities and seizure disorders and may present with pyramidal/extrapyramidal neurologic findings and behavioral problems as well. There are three Cerebral ...

Phase N/A